MicroBplex Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

MicroBplex General Information

Description

Operator of a biotechnology company intended to develop novel technology to detect nascent antibody-secreting cells (ASCs). The company focuses on early detection and assessment of therapeutic effectiveness and distinguishing new infections from prior infections, enabling healthcare professionals to record diagnostic information essential for effective early therapeutic intervention.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1910 Durand Mill Drive
  • Atlanta, GA
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 1910 Durand Mill Drive
  • Atlanta, GA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroBplex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 11-Nov-2025 Completed Out of Business
8. Later Stage VC Completed Generating Revenue
7. Grant 01-Jan-2018 Completed Generating Revenue
6. Grant 08-Sep-2017 Completed Generating Revenue
5. Grant 30-Jun-2016 Completed Generating Revenue
4. Grant 01-Jan-2015 Completed Generating Revenue
3. Grant 28-May-2014 Completed Generating Revenue
2. Grant 01-Jan-2014 $150K Completed Generating Revenue
1. Grant 20-Jul-2012 $25K Completed Generating Revenue
To view MicroBplex’s complete valuation and funding history, request access »

MicroBplex Patents

MicroBplex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210072257-A1 Methods of diagnosing lyme disease Inactive 09-Sep-2019
US-10247729-B2 Media elaborated with newly synthesized antibodies (mensa) and uses thereof Active 05-May-2014
US-20160077094-A1 Media elaborated with newly synthesized antibodies (mensa) and uses thereof Active 05-May-2014
US-20200072836-A1 Media elaborated with newly synthesized antibodies (mensa) and uses thereof Inactive 05-May-2014
EP-2942627-A1 Media elaborated with newly synthesized antibodies (mensa) from recently proliferated antibody secreting cells (asc) and uses thereof Inactive 05-May-2014 G01N33/56972
To view MicroBplex’s complete patent history, request access »

MicroBplex FAQs

  • When was MicroBplex founded?

    MicroBplex was founded in 2011.

  • Where is MicroBplex headquartered?

    MicroBplex is headquartered in Atlanta, GA.

  • What industry is MicroBplex in?

    MicroBplex’s primary industry is Other Devices and Supplies.

  • Is MicroBplex a private or public company?

    MicroBplex is a Private company.

  • What is MicroBplex’s current revenue?

    The current revenue for MicroBplex is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process